P2Y12 inhibitor

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Benoit Lattuca, MD¹; David Belardi, MD¹; Christophe Demattei, MD²; Laurent Schmutz, MD¹; Luc Cornillet, MD¹; Bertrand Ledermann, MD¹; Jean-Christophe Macia, MD³; Ana√Øs Iemmi, MD³; Richard Gervasoni, MD³; Fran√ßois Roubille, MD, PhD³; Thien Tri Cung, MD³; Pierre Robert, MD³; Patrick Messner-Pellenc, MD, PhD¹; Florence Leclercq, MD, PhD³; Guillaume Cayla, MD, PhD¹

Benoit Lattuca, MD1; David Belardi, ...

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology